Stockreport

Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF Exploring potential partnership and strategic opportunities for the Company’s cellular therapy program in Alzheimer’s diseaseHighlighting the Company’s cellular therapy [Read more]